Psyence Biomedical (PBM) Invested Capital (2024 - 2026)

Psyence Biomedical's Invested Capital history runs 3 years deep, the most recent figure standing at $407714.0 for Q1 2026.

• On a quarterly basis, Invested Capital rose 3.41% year-over-year to $407714.0 in Q1 2026; TTM through Mar 2026 was $2.1 million, a 84.31% decrease from a year earlier, with the FY2026 full-year figure at $407714.0, up 3.41% from the prior year.
• Invested Capital advanced to $407714.0 in Q1 2026 per PBM's latest filing, from $394270.0 in the prior quarter.
• Across five years, Invested Capital topped out at $11.4 million in Q1 2024 and bottomed at $394270.0 in Q1 2025.
• The 3-year median for Invested Capital is $830289.0 (2024), against an average of $3.4 million.
• Across the five-year window, Invested Capital slumped 96.56% in 2025 and advanced 3.41% in 2026, its largest moves.
• Year by year, Invested Capital stood at $1.3 million in 2024, then plunged by 68.53% to $394270.0 in 2025, then grew by 3.41% to $407714.0 in 2026.
• Per Business Quant, the three latest PBM Invested Capital figures stand at $407714.0 (Q1 2026), $394270.0 (Q1 2025), and $1.3 million (Q3 2024).